Abbott’s FreeStyle Libre 3 to be made available in upcoming months
People living with diabetes will be able to access the next generation of the FreeStyle Libre in just a matter of months.
Developed by Abbott, the FreeStyle Libre 3 CGM system provides continuous, real-time glucose readings automatically delivered to an individual’s mobile device every minute.
Primarily aimed at people with more complex diabetes management needs, the FreeStyle Libre 3 glucose monitoring system is the latest addition to the world-leading FreeStyle Libre technology.
With a 14-day wear time, the FreeStyle Libre 3 system includes the longest-lasting, self-applied CGM sensor available. The sensor is easy to apply with a one-piece applicator and is worn on the back of the upper arm, eliminating the need for painful finger pricks to view glucose levels.
In addition to the sensor, the system includes the FreeStyle Libre 3 mobile app, which is designed to enable users to capture and view their real-time glucose levels, glucose history and trend arrows showing how their glucose is changing with just a glance at their phone.
The FreeStyle Libre 3 will be made available to the NHS via the NHS Supply Chain Insulin Pumps, Continuous Glucose Monitoring, Closed Loop Insulin Delivery Systems and Associated Products framework.
According to Abbott, the latest system will not replace the FreeStyle Libre 2, with it remaining listed under the Flash Glucose Monitoring system on the NHS Drug Tariff.
Currently, only certain people with diabetes are eligible to access a real-time CGM, including pregnant women, individuals with unstable blood sugars and those who have severe hypos.
To check if you are eligible for a real-time CGM, click here.